Showing results (1131-1140 of 5,058) with videos related to
Sort By:
Pageof 506
Multiple Sclerosis and Related Disorders|March 27, 2026
A real-world study on the long-term efficacy of rituximab in relapsing myelin oligodendrocyte glycoprotein antibody-associated diseaseCairui Yu, Xiaoguang Chen, Wei Jiang, et al.Multiple Sclerosis and Related Disorders|April 15, 2026
Real-world transition from uncontrolled disease to stability: Three-year Pre-post natalizumab comparison in relapsing multiple sclerosisSerkan Ozakbas, Orkhan Mammadov, Said Alizada, et al.Multiple Sclerosis and Related Disorders|April 10, 2026
How useful is the expanded disability status scale to neuropsychiatrists?David E Freedman, Jiwon Oh, Anthony FeinsteinMultiple Sclerosis and Related Disorders|March 31, 2026
Higher ultra-processed food consumption is associated with higher likelihood of paediatric-onset multiple sclerosisPriscila Machado, Hajar Mazahery, Lucinda J Black, et al.Multiple Sclerosis and Related Disorders|March 22, 2026
Patterns of emergency department utilization among persons with multiple sclerosis across seven medical institutionsDominique Kinnett-Hopkins, Jose Sotelo, Lutfiyya N Muhammad, et al.Multiple Sclerosis and Related Disorders|April 20, 2024
Latent tuberculosis prevalence, diagnosis and treatment in Multiple Sclerosis as a strategy for reducing infection reactivation during immunosuppressant therapyGelvana Flávio Barreto Reis, Andrea de Carvalho Anacleto Ferrari de Castro, Eitan Naaman BerezinMultiple Sclerosis and Related Disorders|April 13, 2024
Predictive factors and screening strategy for obstructive sleep apnea in patients with advanced multiple sclerosisC Cousin, J Di Maria, S Hartley, et al.Multiple Sclerosis and Related Disorders|May 15, 2024
Delayed initiation of disease modifying therapy increases relapse frequency and motor disability in pediatric onset multiple sclerosisSaba Jafarpour, Soniya Pinto, My H Vu, et al.Multiple Sclerosis and Related Disorders|May 12, 2024
Absence of JC polyomavirus in stool samples of patients with multiple sclerosis despite high anti-JCV antibodies in serumFinja Schweitzer, Anne Ladwig, Sarah Opala, et al.Multiple Sclerosis and Related Disorders|May 7, 2024
Temporal and spatial patterns in the prescriptions of disease-modifying therapies for multiple sclerosis. Results from the Italian Multiple Sclerosis and Related Disorders RegisterVito Lepore, Pasquale Paletta, Cristina Bosetti, et al.Pageof 506